What is the dosage of Carvykti?

Carvykti is available in 2 dosages, including 1,430,000 cells/ml Injection 70 ml and 3,330,000 cells/ml Injection 30 ml

What does Carvykti treat?

Carvykti treats Multiple Myeloma

What is Carvykti made of?

Carvykti contains ciltacabtagene autoleucel which is a undefined

How is Carvykti administered?

Carvykti is administered as a Injectable

What is Carvykti mechanism of action?

Carvykti mechanism of action is

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Carvykti

(ciltacabtagene autoleucel)

30 ML ciltacabtagene autoleucel 3330000 CELLS/ML Injection [Carvykti]70 ML ciltacabtagene autoleucel 1430000 CELLS/ML Injection [Carvykti]

BLACK BOX WARNING

Dosage & administration

For autologous use only. For intravenous use only.

* Administer a lymphodepleting regimen of cyclophosphamide and fludarabine before infusion of CARVYKTI.
* Do NOT use a leukodepleting filter.
* Verify the patient's identity prior to infusion.
* Premedicate with acetaminophen and an H1-antihistamine.
* Avoid prophylactic use of systemic corticosteroids.
* Confirm availability of tocilizumab prior to infusion.
* Dosing of CARVYKTI is based on the number of chimeric antigen receptor (CAR)-positive viable T cells.
* Recommended dose range is 0.5–1.0×106 CAR-positive viable T cells per kg of body weight, with a maximum dose of 1×108 CAR-positive viable T cells per single-dose infusion.
* Administer CARVYKTI at a REMS-certified healthcare facility.

drug label

Carvykti prescribing information

Have more Carvykti questions?

Submit MSL Request

Learn More

Need to report a Carvykti issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Carvykti samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Carvykti Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

Prior Authorization Checklist

Coverage Authorization Appeal

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Carvykti Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRANDEnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Carvykti Patient education